Stephen Liu: The latest updates on targeting RET in lung cancer

Stephen Liu shared on X/Twitter:

“For the latest updates on targeting RET in lung cancer, listen to this episode of the IASLC podcast, Lung Cancer Considered, where I discuss the current standards and future directions of the field with Drs. Mihaela Aldea and Oliver Gautschi.”

Source: Stephen Liu/X

Stephen Liu is an Associate Professor of Medicine at Georgetown University, where he holds the positions of Director of Thoracic Oncology and Head of Developmental Therapeutics at the Georgetown Lombardi Comprehensive Cancer Center. As a board-certified medical oncologist specializing in lung cancer and drug development, Dr. Liu is known for his expertise in advanced thoracic malignancies. His research focuses on novel therapeutic agents and innovative combinations to improve treatment outcomes for patients with lung cancer. Dr. Liu has received multiple teaching awards and actively engages in post-graduate education initiatives. Furthermore, he co-hosts the official podcast of the International Association for the Study of Lung Cancer (IASLC), “Lung Cancer Considered”.